Choice as an intervention to promote well-being: The role of the nurse prescriber

Journal of Psychiatric and Mental Health Nursing

Volumn 15, Issue 1, 2008, Pages 75-81

  Jones, M ^a,c   Jones, A ^b  

^a SURREY AND BORDERS PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^b BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

^c Ridgewood Centre   (United Kingdom)

Author keywords

Informed choice; Medication management; Nurse prescribing; Partnership working

Indexed keywords

ARTICLE; DECISION MAKING; HEALTH PROMOTION; HUMAN; LEGAL ASPECT; NURSE; NURSE ATTITUDE; PRESCRIPTION; PSYCHIATRIC NURSING;

CHOICE BEHAVIOR; HEALTH PROMOTION; HUMANS; NURSE'S ROLE; NURSES; PRESCRIPTIONS, DRUG; PSYCHIATRIC NURSING;

EID: 37849031790     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2007.01151.x     Document Type: Article

References (36)

1. Alder L.A., Angrist B. Rieter S. (1989) Neuroleptic induced akathisia: a review. Psychopharmacology and schizoaffective disorder. Archives of General Psychiatry 51, 826 836.
2. Ayd F.J. (1961) A survey of drug induced extrapyramidal reactions. JAMA 175, 1054 1060.
3. Baker L.A., Cheng I.Y. Amara I.B. (1983) The withdrawal of benzotropine mesylate in chronic schizophrenic patients. British Journal of Psychiatry 143, 584 590.
4. Barnes T.R.E. McPhillips M.A. (1996) Antipsychotic induced extrapyramidal symptoms. Role of anticholinergic drugs in treatment. CNS Drugs 6, 315 330.
5. Borrison R.L. (1985) Amantadine in the management of extrapyramidal side effects. Clinical Neuropharmacology 6 (Suppl. S57 S63.
6. British National Formulary (2006) September 2006, British Medical Association and Royal Pharmaceutical Society of Great Britain.
7. Casey D.E. (1996) Extrapyramidal syndromes. Epidemiology, pathophysiology and the diagnostic dilemma. CNS Drugs 5 (Suppl. 1 1 12.
8. Casey D.E. Keepers G.A. (1988) Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. In : Psychopharmacology: Current Trends (eds Cassey, D.E. Christensen, A.V.), pp. 62 78. Springer, Berlin.
9. Cassey D.E. (1997) The relationship of pharmacology to side effects. Journal of Clinical Psychiatry 58, 55 62.
10. Department of Health (DoH) (1999) The National Service Framework for Mental Health. The Stationery Office, London.
11. Department of Health (DoH) (2006) Medicines Matters. DoH, London.
12. Gray R., Rofail D., Allen J., et al 2005) A survey of patient satisfaction with and subjective experience of treatment with anti-psychotic medication. Journal of Advanced Nursing 52, 31 37.
13. Gray R., Wykes T. Edmonds M. (2004) Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia, cluster randomised controlled trial. British Journal of Psychiatry 185, 157 162.
14. Hamann J., Kolbe G. Leucht S. (2005) Medication decision making in the mental health field. Psychiatric Services 52, 221.
15. Healthcare Commission (2007) Talking About Medicines. The Management of Medicines in Trusts Providing Mental Health Services. Healthcare Commission, London.
16. Helgason L. (1990) Twenty-year follow up of first psychiatric presentation for schizophrenia: what could have been prevented. Acta Psychiatrica Scandinavica 81, 231 235.
17. Jellineck T., Gardos G. Cole J.O. (1981) Adverse effects of antiparkinson drug withdrawal. Archives of General Psychiatry 35, 483 489.
18. Jones A. (2006) Acute psychiatric inpatient wards. Nurse Prescriber, 1 5. doi: 1017/S1467115806000010
19. Jones A. Harborne G. (2005) Supplementary prescribing in hospital settings. Mental Health Practice 9, 38 40.
20. Jones A. Jones M. (2005) Mental health nurse prescribing: issues for the UK. Journal of Psychiatric and Mental Health Nursing 12, 527 535.
21. Jones M., Bennett J., Gray R., et al. (2006) Management of akathisia by a mental health nurse consultant. Journal of Psychiatric and Mental Health Nursing 13, 26 32.
22. Jones M., Bennett J., Lucas B., et al 2007) Mental health nurse prescribing: experiences of mental health nurses, psychiatrists and patients. Journal of Advanced Nursing 58, 1 9.
23. Jones M. Jones A. (2006) Prescribing new ways of working. Mental Health Practice 9, 20 22.
24. Korsgaad S. Friis T. (1986) Effects of manserin in neuroleptic-induced Parkinsonism. Psychopharmacology 88, 109 111.
25. Lieberman J.A., Stroup T.S., McEvoy M.D., et al 2005) Effects of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209 1223.
26. McIntyre R., McLann S. Kennedy S. (2001) Anti-psychotics metabolic effects: weight gain, diabetes and lipid abnormalities. Canadian Journal of Psychiatry 46, 273 281.
27. Mindham R.H.S., Lamb P. Bradley R. (1977) A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced Parkinsonism. British Journal of Psychiatry 130, 581 585.
28. Munetz M.R. Benjamin S. (1988) How to examine clients using the abnormal involuntary movement scale. Hospital and Community Psychiatry 39, 5 16.
29. National Patient Safety Agency (NPSA) (2006) With Safety in MIND. Mental Health Services and Patient Safety. NPSA, London.
30. National Prescribing Centre (2005) Improving Services by Extending the Role of Mental Health Nurses in Prescribing and Supplying Medication. NPC, Liverpool.
31. Robert R., Colney M.D., Herbert Y., et al. (2000) Adverse events related to Olanazapine. Journal of Clinical Psychiatry 61 (Suppl. 8 26 29.
32. Stahl S.M. (2000) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University press, Cambridge.
33. Szabo E., Moody H., Hamilton T., et al. (1997) Choice of treatment improves quality of life: a study of patients undergoing dialysis. Archives of Internal Medicine 157, 1352 1356.
34. Taylor D., Paton C. Kerwin R. (2005) The South London Maudsley Prescribing Guidelines, 8th edn. Martin Dunitz, London.
35. White J., Gray R. Jones M. (2007) The role of the mental health nurse in the management of aripiprazole. Mental Health Practice 10, 28 30.
36. Zubin J. Spring B. (1977) Vulnerability: a new view on schizophrenia. Journal of Abnormal Psychology 86, 103 126.